January 08, 2016Article
Recurrent stroke in symptomatic carotid stenosis awaiting revascularization
A pooled analysis
Elias Johansson, Elisa Cuadrado-Godia, Derek Hayden, Jakob Bjellerup, Angel Ois, Jaume Roquer, Per Wester, Peter J. Kelly
First published January 8, 2016, DOI: https://doi.org/10.1212/WNL.0000000000002354
Elias Johansson
From the Department of Public Health and Clinical Medicine, Umeå Stroke Centre (E.J., J.B., P.W.), and Department of Pharmacology and Clinical Neuroscience (E.J.), Umeå University, Sweden; Department of Neurology (E.C.-G., A.O., J.R.), Neurovascular Research Group, IMIM-Hospital del Mar (Institut Hospital del Mar d'Investigacions Mèdiques), Universitat Autònoma de Barcelona/DCEXS-Universitat Pompeu Fabra, Spain; and Neurovascular Unit for Translational and Therapeutics Research (D.H., P.J.K.), Mater University Hospital/Dublin Academic Medical Centre, Dublin, Ireland.
Elisa Cuadrado-Godia
From the Department of Public Health and Clinical Medicine, Umeå Stroke Centre (E.J., J.B., P.W.), and Department of Pharmacology and Clinical Neuroscience (E.J.), Umeå University, Sweden; Department of Neurology (E.C.-G., A.O., J.R.), Neurovascular Research Group, IMIM-Hospital del Mar (Institut Hospital del Mar d'Investigacions Mèdiques), Universitat Autònoma de Barcelona/DCEXS-Universitat Pompeu Fabra, Spain; and Neurovascular Unit for Translational and Therapeutics Research (D.H., P.J.K.), Mater University Hospital/Dublin Academic Medical Centre, Dublin, Ireland.
Derek Hayden
From the Department of Public Health and Clinical Medicine, Umeå Stroke Centre (E.J., J.B., P.W.), and Department of Pharmacology and Clinical Neuroscience (E.J.), Umeå University, Sweden; Department of Neurology (E.C.-G., A.O., J.R.), Neurovascular Research Group, IMIM-Hospital del Mar (Institut Hospital del Mar d'Investigacions Mèdiques), Universitat Autònoma de Barcelona/DCEXS-Universitat Pompeu Fabra, Spain; and Neurovascular Unit for Translational and Therapeutics Research (D.H., P.J.K.), Mater University Hospital/Dublin Academic Medical Centre, Dublin, Ireland.
Jakob Bjellerup
From the Department of Public Health and Clinical Medicine, Umeå Stroke Centre (E.J., J.B., P.W.), and Department of Pharmacology and Clinical Neuroscience (E.J.), Umeå University, Sweden; Department of Neurology (E.C.-G., A.O., J.R.), Neurovascular Research Group, IMIM-Hospital del Mar (Institut Hospital del Mar d'Investigacions Mèdiques), Universitat Autònoma de Barcelona/DCEXS-Universitat Pompeu Fabra, Spain; and Neurovascular Unit for Translational and Therapeutics Research (D.H., P.J.K.), Mater University Hospital/Dublin Academic Medical Centre, Dublin, Ireland.
Angel Ois
From the Department of Public Health and Clinical Medicine, Umeå Stroke Centre (E.J., J.B., P.W.), and Department of Pharmacology and Clinical Neuroscience (E.J.), Umeå University, Sweden; Department of Neurology (E.C.-G., A.O., J.R.), Neurovascular Research Group, IMIM-Hospital del Mar (Institut Hospital del Mar d'Investigacions Mèdiques), Universitat Autònoma de Barcelona/DCEXS-Universitat Pompeu Fabra, Spain; and Neurovascular Unit for Translational and Therapeutics Research (D.H., P.J.K.), Mater University Hospital/Dublin Academic Medical Centre, Dublin, Ireland.
Jaume Roquer
From the Department of Public Health and Clinical Medicine, Umeå Stroke Centre (E.J., J.B., P.W.), and Department of Pharmacology and Clinical Neuroscience (E.J.), Umeå University, Sweden; Department of Neurology (E.C.-G., A.O., J.R.), Neurovascular Research Group, IMIM-Hospital del Mar (Institut Hospital del Mar d'Investigacions Mèdiques), Universitat Autònoma de Barcelona/DCEXS-Universitat Pompeu Fabra, Spain; and Neurovascular Unit for Translational and Therapeutics Research (D.H., P.J.K.), Mater University Hospital/Dublin Academic Medical Centre, Dublin, Ireland.
Per Wester
From the Department of Public Health and Clinical Medicine, Umeå Stroke Centre (E.J., J.B., P.W.), and Department of Pharmacology and Clinical Neuroscience (E.J.), Umeå University, Sweden; Department of Neurology (E.C.-G., A.O., J.R.), Neurovascular Research Group, IMIM-Hospital del Mar (Institut Hospital del Mar d'Investigacions Mèdiques), Universitat Autònoma de Barcelona/DCEXS-Universitat Pompeu Fabra, Spain; and Neurovascular Unit for Translational and Therapeutics Research (D.H., P.J.K.), Mater University Hospital/Dublin Academic Medical Centre, Dublin, Ireland.
Peter J. Kelly
From the Department of Public Health and Clinical Medicine, Umeå Stroke Centre (E.J., J.B., P.W.), and Department of Pharmacology and Clinical Neuroscience (E.J.), Umeå University, Sweden; Department of Neurology (E.C.-G., A.O., J.R.), Neurovascular Research Group, IMIM-Hospital del Mar (Institut Hospital del Mar d'Investigacions Mèdiques), Universitat Autònoma de Barcelona/DCEXS-Universitat Pompeu Fabra, Spain; and Neurovascular Unit for Translational and Therapeutics Research (D.H., P.J.K.), Mater University Hospital/Dublin Academic Medical Centre, Dublin, Ireland.
Chinese Translation
Neurology® data supplements are not copyedited before publication. Published editorials
and translations have been copyedited.
© 2016 American Academy of Neurology.
Files in this Data Supplement:
- Chinese Translation - PDF